Showing 1 - 7 results of 7 for search 'Xiaohui Luan', query time: 0.03s Refine Results
  1. 1
    A modified simple RFLP-PCR method for single nucleotide polymorphism (SNP) typing

    A modified simple RFLP-PCR method for single nucleotide polymorphism (SNP) typing by Junhua Xiao, Xiujuan Xin, Xiaohui Luan, Wei Dongzhi, Yang Shengli

    Published 2006-01-01
    Get full text
    Article
  2. 2
    Corrigendum: The role of 18F−FDG PET in predicting the pathological response and prognosis to unresectable HCC patients treated with lenvatinib and PD-1 inhibitors as a conversion therapy

    Corrigendum: The role of 18F−FDG PET in predicting the pathological response and prognosis to unresectable HCC patients treated with lenvatinib and PD-1 inhibitors as a conversion... by Guanyun Wang, Guanyun Wang, Wenwen Zhang, Xiaohui Luan, Xiaohui Luan, Zhanbo Wang, Jiajin Liu, Xiaodan Xu, Jinming Zhang, Baixuan Xu, Shichun Lu, Ruimin Wang, Guangyu Ma

    Published 2023-05-01
    Get full text
    Article
  3. 3
    The role of 18F−FDG PET in predicting the pathological response and prognosis to unresectable HCC patients treated with lenvatinib and PD-1 inhibitors as a conversion therapy

    The role of 18F−FDG PET in predicting the pathological response and prognosis to unresectable HCC patients treated with lenvatinib and PD-1 inhibitors as a conversion therapy by Guanyun Wang, Guanyun Wang, Wenwen Zhang, Xiaohui Luan, Xiaohui Luan, Zhanbo Wang, Jiajin Liu, Xiaodan Xu, Jinming Zhang, Baixuan Xu, Shichun Lu, Ruimin Wang, Guangyu Ma

    Published 2023-05-01
    Get full text
    Article
  4. 4
    Pretreatment Metabolic Parameters Measured by 18F-FDG PET to Predict the Pathological Treatment Response of HCC Patients Treated With PD-1 Inhibitors and Lenvatinib as a Conversion Therapy in BCLC Stage C

    Pretreatment Metabolic Parameters Measured by 18F-FDG PET to Predict the Pathological Treatment Response of HCC Patients Treated With PD-1 Inhibitors and Lenvatinib as a Conversion... by Guanyun Wang, Wenwen Zhang, Jiaxin Chen, Jiaxin Chen, Xiaohui Luan, Xiaohui Luan, Zhanbo Wang, Yanmei Wang, Xiaodan Xu, Shulin Yao, Zhiwei Guan, Jiahe Tian, Shichun Lu, Baixuan Xu, Guangyu Ma

    Published 2022-06-01
    Get full text
    Article
  5. 5
    Tumor angiogenesis at baseline identified by 18F-Alfatide II PET/CT may predict survival among patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy

    Tumor angiogenesis at baseline identified by 18F-Alfatide II PET/CT may predict survival among patients with locally advanced non-small cell lung cancer treated with concurrent che... by Yuchun Wei, Xueting Qin, Xiaoli Liu, Jinsong Zheng, Xiaohui Luan, Yue Zhou, Jinming Yu, Shuanghu Yuan

    Published 2022-02-01
    Get full text
    Article
  6. 6
    A Preclinical Study of an <sup>125</sup>I-Labeled PSMA Ligand for Prostate-Cancer Puncture

    A Preclinical Study of an <sup>125</sup>I-Labeled PSMA Ligand for Prostate-Cancer Puncture by Xiaohui Luan, Haoxi Zhou, Yimin Chen, Xiaojun Zhang, Mengchao Cui, Kuang Chen, Xiaodan Xu, Jinming Zhang, Baixuan Xu

    Published 2022-10-01
    Get full text
    Article
  7. 7
    Multiparameter diagnostic model based on 18F-FDG PET metabolic parameters and clinical variables can differentiate nonmetastatic gallbladder cancer and cholecystitis

    Multiparameter diagnostic model based on 18F-FDG PET metabolic parameters and clinical variables can differentiate nonmetastatic gallbladder cancer and cholecystitis by Can Li, Xiaohui Luan, Xiao Bi, Shengxin Chen, Yue Pan, Jingfeng Zhang, Yun Han, Xiaodan Xu, Guanyun Wang, Baixuan Xu

    Published 2023-02-01
    Get full text
    Article

Search Tools: